Identification of tetracycline combinations as EphB1 tyrosine kinase inhibitors for treatment of neuropathic pain

“Identification of Tetracycline Combinations As EphB1 Tyrosine Kinase Inhibitors for Treatment of Neuropathic Pain”. 2021. Proceedings of the National Academy of Sciences of the United States of America (PNAS).